However, Kohanbash et al.46 have found that reduction of PD-L1 may not result in a stronger T cell response, because D2HG inhibits ATP-dependent T cell receptor signaling, which in turn leads to suppression of T cell anti-tumor immunity. The gene discussed is CD274; the disease is neoplasm.